Personalized Medicine: Molecular Imaging, Radionuclide and Proton-Beam Therapy

个性化医疗：分子成像、放射性核素和质子束治疗

• 批准号: RGPIN-2017-04914
• 负责人: Celler, Anna
• 金额: $ 2.62万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=633074
• 关键词: Personalized; Medicine; Molecular; Imaging; Radionuclide

Nuclear medicine (NM) imaging modalities, such as single positron emission tomography (PET) and single photon emission tomography (SPECT), are already well recognized for their molecular characteristics. They both use biologically active molecules, labeled with radioactive atoms, to provide physicians with diagnostic information about the anatomy and/or physiology of patients. Recently, NM applications have been extended to include targeted radionuclide therapies (TRT), where same molecules labeled with therapeutic agents are used to deliver treatment to locations previously identified in diagnostic studies.

核医学（NM）成像模式，如单正电子发射断层扫描（PET）和单光子发射断层扫描（SPECT），已经很好地认识到他们的分子特征。它们都使用放射性原子标记的生物活性分子，为医生提供有关患者解剖和/或生理的诊断信息。最近，NM应用已经扩展到包括靶向放射性核素疗法（TRT），其中用治疗剂标记的相同分子用于将治疗递送到先前在诊断研究中确定的位置。